UroGen Pharma Ltd.
URGN | NASDAQ
$42.82
-$0.38 (-0.88%)
Sep 22, 2026, 1:07 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 79.13M | 111.3M | 110.75M | 90.04M | 92.9M | 104.03M | 171.99M | 124.92M | 219.97M | 132.26M | 95.82M | 119.31M | 20.13M | 36.54M | 55.41M | 28.69M | 80.69M | 105.38M | 44.36M | 55.34M | 63.32M | 40.49M |
Short-Term Investments | 28.84M | 30.31M | 9.71M | 36.99M | 64.05M | 91.86M | 64.7M | 124.66M | 21.11M | 32.61M | 41.97M | 28.11M | 27.17M | 28.51M | 44.56M | 67.23M | 31.05M | 31.07M | 44.78M | 50.87M | 57.71M | 35.42M |
Long-Term Investments | n/a | 177K | 177K | 380K | 4.63M | 4.51M | 5.02M | 4.64M | 203K | 707K | 4.73M | 6.51M | 7.97M | 10.17M | n/a | n/a | 673K | 674K | 675K | 4.07M | 8.29M | 223K |
Other Long-Term Assets | 8.94M | 7.49M | 5.16M | 6.94M | 978K | 547K | 765K | 545K | 848K | 1.1M | 2.04M | 2.28M | 3.04M | 3.38M | 2.96M | 2.69M | 2.12M | 1.8M | 1.53M | 2M | 1.33M | 66K |
Receivables | 88.76M | 55.41M | 33.08M | 19.7M | 19.65M | 19.64M | 20.3M | 22.8M | 17.42M | 14.16M | 15.44M | 12.85M | 15.51M | 12.49M | 12.7M | 9.43M | 11.6M | 9.5M | 11.72M | 7.78M | 9.51M | 6.3M |
Inventory | 24.59M | 20.92M | 16.46M | 8.34M | 7.13M | 7.59M | 9.23M | 7.59M | 7.44M | 7.24M | 5.67M | 5M | 4.99M | 5.47M | 4.33M | 4.86M | 5.05M | 4.76M | 4.83M | 3.81M | 3.42M | 3.33M |
Other Current Assets | 1.33M | 19.53M | 16.02M | 1.35M | 1.08M | 14.06M | 9.92M | 15.13M | 13.03M | n/a | 10.28M | 16.86M | 13.54M | 12.96M | 11.91M | 812K | 811K | 550K | 1.23M | 1.23M | 1.23M | 1.23M |
Total Current Assets | 235.43M | 237.46M | 186.02M | 168.55M | 196.87M | 237.18M | 276.14M | 295.1M | 278.97M | 196.76M | 169.19M | 182.12M | 81.33M | 95.97M | 128.91M | 121.59M | 139.62M | 160.52M | 114.39M | 125.14M | 140.5M | 93.08M |
Property-Plant & Equipment | 8.23M | 8.56M | 9.09M | 9.18M | 6.24M | 5.38M | 3.79M | 1.66M | 1.83M | 2.01M | 2.36M | 2.73M | 3.02M | 3.43M | 3.75M | 4.19M | 3.72M | 2.72M | 3.15M | 3.4M | 3.65M | 4.04M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 17.16M | 16.23M | 14.43M | 16.5M | 11.85M | 10.44M | 9.58M | 6.85M | 2.88M | 3.81M | 9.13M | 11.51M | 14.03M | 16.98M | 6.71M | 6.88M | 6.52M | 5.19M | 5.36M | 9.46M | 13.27M | 4.33M |
Total Assets | 252.59M | 253.69M | 200.46M | 185.05M | 208.72M | 247.62M | 285.71M | 301.94M | 281.85M | 200.57M | 178.31M | 193.63M | 95.36M | 112.95M | 135.62M | 128.47M | 146.14M | 165.72M | 119.75M | 134.6M | 153.77M | 97.41M |
Account Payables | 39.95M | 17.21M | 12.14M | 10.28M | 13.56M | 14.57M | 10.93M | 5.56M | 8.32M | 6.26M | 6.51M | 4.04M | 4.66M | 6.97M | 5.53M | 2.55M | 2.46M | 4.23M | 5.79M | 4.06M | 4.83M | 6.1M |
Deferred Revenue | n/a | 8.28M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5.24M | 4.39M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | 1.92M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 779K | 819K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 7.62M | 13.4M | 18.7M | 3.37M | 3.39M | 11.68M | 18.52M | 13.1M | 10.47M | -2.82M | -1.35M | 11.71M | 10.36M | 8.1M | 11.53M | 9.64M | 9.39M | 9.16M | 10.28M | 8.74M | 8.71M | 6.45M |
Total Current Liabilities | 61.92M | 50.64M | 46.42M | 42.24M | 47.55M | 42M | 45.95M | 32.79M | 34.22M | 26.34M | 31.21M | 25.79M | 26.77M | 25.23M | 23.92M | 19M | 18.04M | 19.09M | 22.38M | 19.81M | 19.06M | 17.01M |
Long-Term Debt | 188.73M | 189.53M | 122.21M | 122.11M | 122.51M | 122.11M | 121.73M | 121.71M | 97.81M | 97.59M | 98.55M | 98.52M | 98.3M | 97.94M | 97.54M | 71.87M | 71.2M | 70.8M | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 129.04M | 132.13M | 131.18M | 129.86M | 128.62M | 127.13M | 125.18M | 121.72M | 119.07M | 116.14M | 112.92M | 107.28M | 104.51M | 101.91M | 98.92M | 96.19M | 93.46M | 89.78M | 85.71M | 79.93M | 74.8M | n/a |
Total Long-Term Liabilities | 323.07M | 327.31M | 259.51M | 258.21M | 254.55M | 252.08M | 248.57M | 243.64M | 217.31M | 214.37M | 212.31M | 209.84M | 207.03M | 204.27M | 201.06M | 172.76M | 169.01M | 163.7M | 88.95M | 83.26M | 78.44M | 3.92M |
Total Liabilities | 384.99M | 377.94M | 305.93M | 300.45M | 302.09M | 294.08M | 294.51M | 276.43M | 251.54M | 240.71M | 243.52M | 235.63M | 233.8M | 229.51M | 224.98M | 191.76M | 187.05M | 182.79M | 111.33M | 103.07M | 97.5M | 20.92M |
Total Debt | 196.13M | 197.09M | 128.33M | 129.94M | 127.47M | 124.95M | 123.39M | 121.92M | 98.24M | 99.01M | 100.21M | 99.54M | 99.51M | 99.34M | 99.12M | 73.73M | 72.71M | 71.07M | 398K | 616K | 922K | 1.2M |
Book Value | -132.4M | -124.25M | -105.47M | -115.41M | -93.38M | -46.46M | -8.8M | 25.52M | 30.31M | -40.13M | -65.21M | -41.99M | -138.43M | -116.55M | -89.36M | -63.29M | -40.91M | -17.07M | 8.41M | 31.54M | 56.27M | 76.49M |
Book Value Per Share | -2.63 | -2.48 | -2.14 | -2.40 | -1.96 | -0.98 | -0.19 | 0.59 | 0.82 | -1.20 | -1.80 | -1.30 | -5.90 | -5.01 | -3.87 | -2.78 | -1.80 | -0.75 | 0.38 | 1.41 | 2.52 | 3.44 |
Common Stock | 135K | 134K | 133K | 128K | 126K | 126K | 115K | 115K | 112K | 99K | 89K | 84K | 64K | 64K | 63K | 63K | 62K | 62K | 61K | 61K | 61K | 61K |
Retained Earnings | -997.64M | -983.29M | -959.72M | -933.35M | -900.01M | -850.07M | -806.22M | -768.71M | -745.04M | -711.63M | -679.35M | -653.33M | -631.45M | -607.32M | -577.1M | -548.24M | -522.4M | -495.71M | -467.32M | -438.87M | -408.66M | -382.44M |
Comprehensive Income | -2K | 8K | 19K | 23K | 6K | 14K | 56K | 236K | -31K | -37K | 12K | -134K | -154K | -45K | -107K | -155K | -56K | -69K | -25K | 4K | 45K | 143K |
Shareholders Equity | -132.4M | -124.25M | -105.47M | -115.41M | -93.38M | -46.46M | -8.8M | 25.52M | 30.31M | -40.13M | -65.21M | -41.99M | -138.43M | -116.55M | -89.36M | -63.29M | -40.91M | -17.07M | 8.41M | 31.54M | 56.27M | 76.49M |
Total Investments | 28.84M | 30.48M | 9.89M | 37.37M | 68.68M | 96.37M | 69.72M | 129.3M | 21.31M | 33.31M | 46.69M | 34.62M | 35.14M | 38.68M | 44.56M | 67.23M | 31.72M | 31.74M | 45.45M | 54.94M | 66M | 35.64M |
Add to Watchlist
Select watchlists to add or remove URGN